A Global Phase 2 Study of Valemetostat Tosylate (Valemetostat) in Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL), Including R/R Adult T-Cell Leukemia/Lymphoma (ATL) - Valentine-PTCL01

被引：11
|
作者：
Foss, Francine M. [1 ]
Porcu, Pierluigi [2 ]
Horwitz, Steven M. [3 ]
Izutsu, Koji [4 ]
Ishitsuka, Kenji [5 ]
Kato, Kazunobu [6 ]
Jin, Jin [6 ]
Du, Yining [6 ]
Inoue, Ai [6 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Thomas Jefferson Univ, Philadelphia, PA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Natl Canc Ctr, Dept Hematol, Tokyo, Japan
[5] Kagoshima Univ Hosp, Div Hematol & Immunol, Kagoshima, Japan
[6] Daiichi Sankyo Inc, Basking Ridge, NJ USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-144676
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2533
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Efficacy and Safety of Valemetostat Monotherapy in Patients with Relapsed or Refractory Peripheral T-Cell Lymphomas: Primary Results of the Phase 2 VALENTINE-PTCL01 Study
    Horwitz, Steven M.
    Izutsu, Koji
    Mehta-Shah, Neha
    Cordoba, Raul
    Barta, Stefan K.
    Bachy, Emmanuel
    Gritti, Giuseppe
    Jacobsen, Eric
    Kusumoto, Shigeru
    Guillermin, Yann
    Prica, Anca
    Yoon, Dok Hyun
    Domenech, Eva Domingo
    Wang, Jie
    Kim, Jin Seok
    Cwynarski, Kate
    van der Poel, Marjolein
    Inoue, Ai
    Jin, Jin
    Wu, Sutan
    Nakajima, Keiko
    Zinzani, Pier Luigi
    [J]. BLOOD, 2023, 142
  • [2] Responses to romidepsin by line of therapy in patients with relapsed/refractory (R/R) peripheral T-cell lymphoma (PTCL).
    Foss, Francine M.
    Pro, Barbara
    Prince, H. Miles
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Horwitz, Steven M.
    Coiffier, Bertrand
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] COMPLETE RESPONSES (CR/CRU) ON A PHASE 2 STUDY OF ROMIDEPSIN IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (R/R PTCL)
    Pro, B.
    Horwitz, S.
    Foss, F.
    Prince, M.
    Sokol, L.
    Greenwood, M.
    Caballero, D.
    Borchmann, P.
    Nichols, J.
    Balser, J.
    Carroll, S.
    Coiffier, B.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 201 - 202
  • [4] Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL)
    Horwitz, S. M.
    Coiffier, B.
    Foss, F. M.
    Prince, H. M.
    Sokol, L.
    Greenwood, M.
    Caballero, D.
    Borchmann, P.
    Morschhauser, F.
    Wilhelm, M.
    Pinter-Brown, L. C.
    Padmanabhan, S.
    Shustov, A. R.
    Nichols, J.
    Balser, J.
    Carroll, S.
    Pro, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Subsequent Hematopoietic Stem Cell Transplantation in Belinostat-Treated Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
    Shustov, Andrei R.
    Al-Ali, Haifa Kathrin
    Wulf, Gerald
    Hsu, Pamela
    Choi, Mi Rim
    Allen, Lee F.
    Visser, Otto J.
    Zachee, Pierre
    Horwitz, Steven M.
    [J]. BLOOD, 2014, 124 (21)
  • [6] Multicenter Phase I Dose-Escalation Study of Lenalidomide in Patients with Relapsed Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL)
    Uike, Naokuni
    Ogura, Michinora
    Imaizumi, Yoshitaka
    Asou, Norio
    Utsunomiya, Atae
    Uchida, Toshiki
    Aoki, Tomohiro
    Tsukasaki, Kunihiro
    Taguchi, Jun
    Choi, Ilseung
    Maruyama, Dai
    Nosaka, Kisato
    Chen, Nianhang
    Shiota, Tetsuhiro
    Tobinai, Kensei
    [J]. BLOOD, 2012, 120 (21)
  • [7] A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)
    Chavez, Julio C.
    Foss, Francine M.
    William, Basem M.
    Brammer, Jonathan E.
    Smith, Sonali M.
    Prica, Anca
    Zain, Jasmine M.
    Tuscano, Joseph M.
    Glenn, Martha
    Mehta-Shah, Neha
    Wang, Ben X.
    Zantinge, Stephanie
    Wang, Lisa
    Zhang, Ling
    Boutrin, Anmarie
    Zhao, Weiguang
    Cheng, Lily
    Standifer, Nathan
    Carlesso, Gianluca
    Moscow, Jeffrey
    Siu, Lillian
    [J]. BLOOD, 2020, 136
  • [8] Two Phase I and Pharmacokinetic Studies of Darinaparsin (Organic Arsenic Compound) in Japanese and Korean Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)
    Kim, Won-Seog
    Ogura, Michinori
    Uchida, Toshiki
    Uike, Naokuni
    Abe, Yasunobu
    Ishizawa, Kenichi
    Okitsu, Yoko
    Tobinai, Kensei
    Nagahama, Fumiko
    Sonehara, Yusuke
    Nagai, Hirokazu
    [J]. BLOOD, 2015, 126 (23)
  • [9] Case Match Control Analysis of Propel Reveals Survival Advantage for Patients with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) Treated with Pralatrexate
    O'Connor, Owen A.
    Marchi, Enrica
    Volinn, Weining
    Kim, Won Seog
    [J]. BLOOD, 2016, 128 (22)
  • [10] Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)
    Maeda, Yoshinobu
    Tobinai, Kensei
    Nagai, Hirokazu
    Nakane, Takahiko
    Shimoyama, Tatsu
    Nakazato, Tomonori
    Sakai, Rika
    Ishikawa, Takayuki
    Izutsu, Koji
    Ueda, Ryuzo
    [J]. BLOOD, 2016, 128 (22)
12345